Hepatitis C

 
CDC Updates HCV Screening Guidelines to Increase Linkage to Care
August 16, 2023

The CDC update recommends ending screening strategies that require multiple clinic visits for sample collection, favoring 1 visit and automatic HCV RNA testing.

Daily Dose: Universal DAA Therapy for all Persons with HCV
January 09, 2023

Your daily dose of clinical news you may have missed.

New Findings Underscore Need for Universal DAA Therapy for all Persons with Hepatitis C Virus Infection
January 06, 2023

Direct-acting antiviral treatment was independently associated with a lower risk of mortality and liver and nonliver outcomes in a large study of adults with chronic hepatitis C.

Less Than One-third of Adults with HCV Get Timely Treatment, According to New CDC Report
August 10, 2022

Timely initiation of DAA treatment, regardless of insurance type, is crucial in reducing HCV-related death, disparity, and transmission, concluded CDC researchers.

HCV Cure is Possible in Young Drug Users, Suggests New Research Being Presented at IDWeek 2021
September 28, 2021

IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.

ACP: Ensure Adult Routine Vaccinations are Up to Date as Flu and COVID Meet Again
August 18, 2021

The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.

NAFLD & NASH in Primary Care: Facts, Definitions, & Figures in Brief
April 13, 2021

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is increasing and early detection is critical. Brush up on basics with our slides.

Beyond Boomers: CDC Urges HCV Screening for All US Adults
August 14, 2020

HCV is now diagnosed in millennials at about the same rate as in baby boomers; CDC responds with a recommendation for HCV screening in all adults aged ≥18 years.

Novel Study Suggests HCV-positive Livers Safe for Transplantation
June 24, 2020

Patients who received an HCV-positive liver for transplantation and were later treated performed as well in recovery as those who did not, a recent study suggests.